Key result
Non-complex LAAO in patients ≥80 years is linked to ~14% lower effectiveness than in younger patients.
Why the study?
Complex periprocedural approaches contrast with the need of oldest-old patients to keep medical procedures simple and short.
Is a simplified non-complex LAAO procedure effective and safe in oldest-old patients (≥ 80 years) compared to younger patients?
Cohort (n=230)
No
Is a simplified non-complex LAAO procedure effective and safe in oldest-old patients (≥ 80 years) compared to younger patients?
Non-complex LAAO is technically feasible with a low complication rate in oldest-old patients, though they experience lower overall effectiveness and a trend toward higher mortality and ischemic strokes compared to younger patients.
Answers are grounded in this paper and cite their sources.
Lower effectiveness in oldest-old patients warrants caution with non-complex LAAO; leaves open whether age-specific strategies improve outcomes.
BACKGROUND AND AIM: Complex periprocedural approaches contrast with the need of oldest-old patients to keep medical procedures simple and short. This study investigates the effectiveness and safety of a simplified non-complex LAAO procedure. METHODS: All patients who received an LAAO procedure at our center since 2014 with available follow-up data were retrospectively assessed concerning effectiveness in preventing all-cause death, stroke, or systemic embolism (i.e., effectiveness outcome). Safety was primarily evaluated by major bleeding (i.e., ≥ BARC type 3). Oldest-old patients (i.e., ≥ 80 years of age) were compared with younger patients. RESULTS: 43.0 % of 230 patients were oldest-olds. High technical success rate was achieved in both groups (oldest-olds 96.0 vs. younger patients 98.5 %; p = 0.41). Major complications occurred in 8.1 vs. 3.8 % of patients (p = 0.17). Effectiveness outcome was achieved in 70.7 vs. 82.4 % of patients (p = 0.035; mean follow-up 428 (100; 1007) and 382 (179; 1192) days). Oldest-old patients trended to an excess mortality (22.2 vs. 13.0 %; p = 0.064) and more ischemic strokes (10.1 vs. 3.8 %; p = 0.056). This was not associated with peri-device leaks ≥ 5 mm or device-related thromboses (2.0 vs. 1.5 %; p = 1.00). Major bleeding occurred in 9.1 vs. 7.6 % of patients over total follow-up (p = 0.69). CONCLUSIONS: Non-complex LAAO procedure achieved a state-of-the-art technical success rate and a low complication rate in vulnerable oldest-old patients. Care should be taken to identify patients with sufficient life expectancy to benefit from LAAO. The trend towards more ischemic strokes during follow-up is an important signal focusing on cardioembolic stroke etiologies besides LAA thrombi in these patients.
No takes yet. Share an insight, caveat, or question.
Fastner et al. (2025) conducted a cohort in Patients receiving LAAO (n=230). Oldest-old age (≥ 80 years) vs. Younger patients was evaluated on Effectiveness in preventing all-cause death, stroke, or systemic embolism (p=0.035). Among patients undergoing non-complex LAAO, oldest-old patients (≥80 years) achieved the effectiveness outcome less frequently than younger patients.
Synapse has enriched 10 related papers. Consider them for comparative context: